Fig. 6
From: m1A methylation modification patterns and metabolic characteristics in hepatocellular carcinoma
Characteristics of m1Ascore and drug screening. a Overall survival of high and low m1Ascore groups and the survival difference was evaluated by log-rank test. b Clinicopathological characteristics in high and low m1Ascore groups. c Heatmap visualizing the activation states of biological pathways in high and low m1Ascore groups. The pathways achieved from the HALLMARK gene sets. d Somatic mutation landscapes in high and low m1Ascore groups. e–f Drug response analysis of the potential compounds e derived from PRISM and f CTRP